S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
Log in
NASDAQ:ARWR

Arrowhead Pharmaceuticals SEC Filings & 10K Form

$69.00
-0.56 (-0.81 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$62.99
Now: $69.00
$70.50
50-Day Range
$69.56
MA: $83.27
$90.47
52-Week Range
$19.51
Now: $69.00
$92.60
Volume1.61 million shs
Average Volume857,442 shs
Market Capitalization$7.16 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.62

SEC Filings

Arrowhead Pharmaceuticals (NASDAQ:ARWR) SEC Filings

DateFilerForm TypeView
02/24/2021
5:51 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2021
4:56 PM
Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2021
9:30 AM
Arrowhead Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/04/2021
3:10 PM
Arrowhead Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/04/2021
3:05 PM
Arrowhead Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2021
8:54 PM
Arrowhead Pharmaceuticals (Filer)
Form DEF 14A
01/19/2021
4:58 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2021
4:49 PM
Arrowhead Pharmaceuticals (Issuer)
Hamilton James C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2021
5:06 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
5:05 PM
Arrowhead Pharmaceuticals (Issuer)
Hassard James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2021
5:11 PM
Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2021
5:08 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2021
5:02 PM
Arrowhead Pharmaceuticals (Issuer)
Hamilton James C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
5:27 PM
Arrowhead Pharmaceuticals (Issuer)
Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
5:24 PM
Arrowhead Pharmaceuticals (Issuer)
Ferrari Mauro (Reporting)
Ferrari Mauro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
5:22 PM
Arrowhead Pharmaceuticals (Issuer)
Arrowhead Pharmaceuticals (Issuer)
De Backer Marianne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
5:20 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
5:16 PM
Arrowhead Pharmaceuticals (Issuer)
OLUKOTUN ADEOYE Y (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
5:14 PM
Arrowhead Pharmaceuticals (Issuer)
PERRY MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
5:11 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
5:07 PM
Arrowhead Pharmaceuticals (Issuer)
Hamilton James C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
5:01 PM
Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
5:02 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2020
4:52 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2020
4:55 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2020
4:55 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
5:26 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
5:16 PM
Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2020
6:07 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/23/2020
4:58 PM
Arrowhead Pharmaceuticals (Issuer)
Bradshaw Curt (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/23/2020
3:34 PM
Arrowhead Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
11/20/2020
5:03 PM
Arrowhead Pharmaceuticals (Issuer)
San Martin Javier (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2020
4:49 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2020
5:11 PM
Arrowhead Pharmaceuticals (Issuer)
Arrowhead Pharmaceuticals (Issuer)
Hamilton James C (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/26/2020
5:02 PM
Arrowhead Pharmaceuticals (Issuer)
De Backer Marianne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2020
6:35 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2020
5:02 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2020
5:01 PM
Arrowhead Pharmaceuticals (Issuer)
Ferrari Mauro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2020
4:00 PM
Arrowhead Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2020
5:31 PM
Arrowhead Pharmaceuticals (Issuer)
OLUKOTUN ADEOYE Y (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/08/2020
6:35 AM
Arrowhead Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2020
5:08 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2020
4:14 PM
Arrowhead Pharmaceuticals (Filer)
Form 424B5
06/26/2020
5:02 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
5:10 PM
Arrowhead Pharmaceuticals (Issuer)
De Backer Marianne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
5:27 PM
Arrowhead Pharmaceuticals (Issuer)
PERRY MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2020
5:48 PM
Arrowhead Pharmaceuticals (Issuer)
PERRY MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2020
5:45 PM
Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2020
6:19 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2020
6:00 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2020
6:47 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
4:18 PM
Arrowhead Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2020
1:47 PM
Arrowhead Pharmaceuticals (Subject)
FIRST MANHATTAN CO (Filed by)
Form SC 13G/A
01/28/2020
3:31 PM
Arrowhead Pharmaceuticals (Filer)
Form DEF 14A
01/23/2020
5:15 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
4:00 PM
Arrowhead Pharmaceuticals (Filer)
Form PRE 14A
01/13/2020
4:13 PM
Arrowhead Pharmaceuticals (Issuer)
Hassard James (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2020
5:35 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
5:33 PM
Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
5:31 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
5:10 PM
Arrowhead Pharmaceuticals (Issuer)
De Backer Marianne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
5:08 PM
Arrowhead Pharmaceuticals (Issuer)
PERRY MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
5:06 PM
Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
5:04 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
5:02 PM
Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2019
3:54 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2019
3:51 PM
Arrowhead Pharmaceuticals (Issuer)
De Backer Marianne (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/13/2019
5:35 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
8:55 PM
Arrowhead Pharmaceuticals (Filer)
Form 424B5
12/04/2019
5:48 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2019
3:48 PM
Arrowhead Pharmaceuticals (Filer)
Form 424B5
12/02/2019
3:02 PM
Arrowhead Pharmaceuticals (Filer)
Form S-3ASR
11/25/2019
3:11 PM
Arrowhead Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
11/25/2019
3:05 PM
Arrowhead Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2019
5:48 PM
Arrowhead Pharmaceuticals (Issuer)
Bradshaw Curt (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/20/2019
5:44 PM
Arrowhead Pharmaceuticals (Issuer)
San Martin Javier (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/07/2019
5:45 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2019
6:32 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2019
6:31 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2019
9:56 AM
Arrowhead Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
09/27/2019
8:16 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2019
8:12 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2019
7:09 PM
Arrowhead Pharmaceuticals (Issuer)
PERRY MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2019
3:09 PM
Arrowhead Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2019
3:03 PM
Arrowhead Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2019
6:19 PM
Arrowhead Pharmaceuticals (Issuer)
Ferrari Mauro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
5:12 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2019
6:01 PM
Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2019
5:57 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
4:44 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
3:12 PM
Arrowhead Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/19/2019
4:10 PM
Arrowhead Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2019
5:57 PM
Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2019
3:55 PM
Arrowhead Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/18/2019
2:17 PM
Arrowhead Pharmaceuticals (Filer)
Form CT ORDER
03/15/2019
4:09 PM
Arrowhead Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2019
7:42 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
6:08 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN BRUCE D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
6:32 PM
Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2019
7:12 PM
Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.